<p>Hepsin Promotes Epithelial–Mesenchymal Transition and Cell Invasion Through the miR-222/PPP2R2A/AKT Axis in Prostate Cancer</p>-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Hepsin Promotes Epithelial–Mesenchymal Transition and Cell Invasion Through the miR-222/PPP2R2A/AKT Axis in Prostate Cancer

Published:2020-11 Issue: Volume:Volume 13 Page:12141-12149
ISSN:1178-6930
Container-title:OncoTargets and Therapy
language:en
Short-container-title:OTT

Author:

Li Ruiqian,Li Jun,Yang Hong,Bai Yu,Hu Chen,Wu Hongyi,Jiang Haiyang,Wang Qilin

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Oncology

Reference45 articles.

1. Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A. Global cancer statistics, 2012. CA Cancer J Clin. 2015;65(2):87–108. doi:10.3322/caac.21262

2. Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424. doi:10.3322/caac.21492

3. SLUG promotes prostate cancer cell migration and invasion via CXCR4/CXCL12 axis

4. The androgen-regulated type II serine protease TMPRSS2 is differentially expressed and mislocalized in prostate adenocarcinoma

5. Hepsin is Highly Over Expressed in and a New Candidate for a Prognostic Indicator in Prostate Cancer

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Global changes of miRNA expression indicates an increased reprogramming efficiency of induced mammary epithelial cells by repression of miR-222-3p in fibroblasts;PeerJ;2024-07-12

2. New insight in urological cancer therapy: From epithelial-mesenchymal transition (EMT) to application of nano-biomaterials;Environmental Research;2023-07

3. Venetoclax is a potent hepsin inhibitor that reduces the metastatic and prothrombotic phenotypes of hepsin-expressing colorectal cancer cells;Frontiers in Molecular Biosciences;2023-05-19

4. Extracellular: Plasma Membrane Proteases – Serine Proteases;Encyclopedia of Cell Biology;2023

5. Circulating plasma miR222‐3P status and its potential diagnostic performance in prostate cancer;The Journal of Gene Medicine;2022-11-09

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3